Eurobio Scientific announced the launch of a new proprietary test, EurobioPlex SARS-CoV-2 Fast Screening & Variants Detection (SARS-CoV -2 Fast-SVD, EBX-047), a real-time multiplex PCR test for the detection of the SARS-CoV-2 coronavirus and the Delta and Omicron variants. EBX-047 is a kit developed and manufactured in France by Eurobio Scientific, allowing, in a single PCR well, the screening of the coronavirus and the detection of the two currently predominant variants, including Omicron, which could present a risk of immune escape. The test performs a standard screening with two genes, and targets the L452R mutation present on the Delta variant, and the K417N mutation present on the Omicron variant. This orientation test with a very fast (45 minutes) PCR phase, is integrated with the other tests in the EurobioPlex range for open instruments available in large hospital and private medical biology laboratories. With this new test adapted to the Omicron variant, Eurobio Scientific confirms its continued investment to design and develop the tools necessary to manage and fight against the current pandemic and its evolution. The SARS-CoV-2 Fast-SVD kit is thus the first test to enable real time monitoring of the spread of the Omicron variant, and in the context of global health monitoring, to explore its possible ability to escape the immune system of vaccinated patients. The "Polymerase Chain Reaction" (PCR) is a method based on the selective multiplication of target DNA sequences, which makes it possible to detect specific DNA sequences present in a product.